BRTX
BRTX
NASDAQ · Biotechnology

Biorestorative Therapies Inc

$0.30
+0.00 (+0.41%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +8,705.5% upside
Low Target $18.72
Average Target $26.17
High Target $39.89
Current Price $0.30
Current
$0.30
Target
$26.17
$18.72 $26.17 avg $39.89
Scenario Analysis
Bear Case
$18.72
6,198.8%
Low target
Base Case
$26.17
+8,705.5%
Avg target
Bull Case
$39.89
+13,321.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.05
-85.5% from high
52-Week Low
$0.19
+56.4% from low
Target vs 52W High
$26.17
+1,179.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%